Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preliminary Feasibility and Clinical Effectiveness of a Single-Session Intervention on the Neurocognitive Functioning of Children and Adolescents With Neurofibromatosis Type 1

NCT05377008 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT05377008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05377008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preliminary Feasibility and Clinical Effectiveness of a Single-Session Intervention on the Neurocognitive Functioning of Children and Adolescents With Neurofibromatosis Type 1
Lead sponsor
Virginia Commonwealth University
Phase
Not applicable
Overall status
Completed
Start date
May 13, 2022
Completion date
May 5, 2023
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mental health impairment, neurocognitive deficit, neurofibromatosis 1